Support for the Rose F. Kennedy IDD Research Center
Support for the Rose F. Kennedy IDD Research Center
批准号:
8246586
负责人:
Steven Upshaw Walkley
金额:
$109.73万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-26 至 2016-06-30
中文摘要
描述(由申请人提供):玫瑰F的首要目标。肯尼迪智力和发育障碍研究中心(RFK-IDDRC)是通过研究和临床推广来改善智力和发育障碍儿童的生活。作为NICHD的旗舰IDDRCs之一,在基础研究和临床护理方面有着40年的杰出历史,加上爱因斯坦最近重要的教师招聘和设施发展,共同播下了肯尼迪中心IDD计划的种子。对这一过程至关重要的是新的肯尼迪中心领导团队提供了合作与协作的愿景,使实验室科学家和临床医生相互交织,共同目标是将简单系统中的研究转化为与患者健康直接相关的临床见解和治疗。四个研究主题体现了爱因斯坦的基础科学优势和布朗克斯及周边人群固有的关键IDD相关临床问题,已经确定了支持这些领域研究进展所必需的关键科学核心。研究主题集中在自闭症谱系障碍,神经遗传和癫痫发作障碍,
脑发育的营养和环境决定因素,以及耳聋和沟通障碍。 六个科学核心旨在为人类和动物的表型分析、神经元和全脑成像、细胞和组织操作以及遗传分析提供手段,每个核心都以战略为中心,以促进实验室研究和患者护理。这项工作的合作伙伴包括神经科学和遗传学的强大研究引擎和爱因斯坦沿着的其他关键学术部门以及肯尼迪中心的临床附属机构-儿童评估和鉴定中心(CERC)和蒙蒂菲奥里儿童医院(CHAM)。这些临床中心及其贡献的临床部门服务于该国最需要的城市人口之一,其中智力和发育障碍发生在经济贫困和服务不足的种族混合少数群体中。这些卓越的研究和临床资源,再加上一个reinvorgorate和鼓舞人心的领导和计划,提供了一个新时代的基础,为玫瑰F。肯尼迪中心,因为它努力实现其改善智力和发育障碍儿童的生活的目标。
公共卫生相关性(见说明):智力和发育障碍(IDD)是涉及儿童的最重要的健康影响类别之一,仅在美国就影响数十万人。这项建议的目的是建立一个碘缺乏病研究中心,玫瑰F。肯尼迪IDDRC,作为一种手段,以促进尖端的科学和转化研究在神经科学和遗传学加上专门的,深入的临床工作,重点是诊断和病人护理计划。
英文摘要
DESCRIPTION (provided by applicant): The overarching goal of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (RFK-IDDRC) is to improve the lives of children with intellectual and developmental disabilities through research and clinical outreach. Forty years of distinguished history in basic research and clinical care as one ofthe flagship IDDRCs of NICHD, coupled with important recent faculty recruitments and facility developments at Einstein have, in concert, sown the seeds of a rennaissance in the Kennedy Center IDD program. Critical to this process is a new Kennedy Center leadership team providing a vision of cooperation and collaboration whereby bench scientists and clinicians work intertwined toward the common goal of translating studies in simple systems to clinical insight and therapies with direct relevance to patient health. Four research themes embodying both the basic science strengths at Einstein and critical IDD-related clinical issues inherent in the Bronx and surrounding populations have been identified, as have key scientific cores essential for supporting research advances in these areas. Research themes are focused on the overlapping and ail-important areas of Autism Spectrum Disorders, Neurogenetic and Seizure Disorders,
Nutritional and Environmental Determinants of Brain Development, and Deafness and Communication Disorders. Six scientific cores are designed to provide the means for both human and animal phenotyping, neuron and whole brain imaging, cell and tissue manipulation, and genetic analyses, with each centered strategically to provide advancements in bench research and patient care. Partners in this effort include the powerful research engines of Neuroscience and Genetics and other key academic departments at Einstein along with the Kennedy Center's clinical affiliates - the Children's Evaluation and Rehabiltiation Center (CERC) and the Children's Hospital At Montefiore (CHAM). These clinical centers and their contributing clinical departments serve one of the neediest urban populations in the country, where intellectual and developmental disabilities occur in economically deprived, and underserved racially-mixed minority populations. These remarkable research and clincial resources, coupled with a reinvorgorate and inspired leadership and program, provide the basis for a new era for the Rose F. Kennedy Center as it strives toward its goal of improving the lives of children with intellectual and developmental disabilities.
PUBLIC HEALTH RELEVANCE (See Instructions): Intellectual and Developmental Disabilities (IDD) represent one of the most significant categories of health impact involving children, affecting hundreds of thousands of individuals in the US alone. The purpose of this proposal is to establish an IDD research center, the Rose F. Kennedy IDDRC, as a means to promote a program of cutting-edge scientific and translational research in neuroscience and genetics coupled with dedicated, indepth clinical efforts focused on diagnosis and patient care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADMIN CORE
-
批准号:10669061
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2021
-
负责人:Steven Upshaw Walkley
-
依托单位:
ADMIN CORE
-
批准号:10455675
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2021
-
负责人:Steven Upshaw Walkley
-
依托单位:
ADMIN CORE
-
批准号:10239748
-
项目类别:
-
资助金额:$16.67万
-
财政年份:2021
-
负责人:Steven Upshaw Walkley
-
依托单位:
2015 Lysosomal Disease Gordon Research Conference and Gordon Research Seminar
-
批准号:8830513
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2014
-
负责人:Steven Upshaw Walkley
-
依托单位:
2013 Lysosomal Disease Gordon Research Conference and Gordon Research Seminar
-
批准号:8526613
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2013
-
负责人:Steven Upshaw Walkley
-
依托单位:
Support for the Rose F. Kennedy IDD Research Center
-
批准号:8507783
-
项目类别:
-
资助金额:$107.09万
-
财政年份:2011
-
负责人:Steven Upshaw Walkley
-
依托单位:
Support for the Rose F. Kennedy IDD Research Center
-
批准号:9184669
-
项目类别:
-
资助金额:$97.84万
-
财政年份:2011
-
负责人:Steven Upshaw Walkley
-
依托单位:
Support for the Rose F. Kennedy IDD Research Center
-
批准号:8338915
-
项目类别:
-
资助金额:$110.63万
-
财政年份:2011
-
负责人:Steven Upshaw Walkley
-
依托单位:
2011 Lysosomal Disease Gordon Research Conference
-
批准号:8056180
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2010
-
负责人:Steven Upshaw Walkley
-
依托单位:
2011 Lysosomal Disease Gordon Research Conference
-
批准号:8180232
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2010
-
负责人:Steven Upshaw Walkley
-
依托单位:
The Glycoproteinoses: Second International Workshop on Advances in Pathogenesis a
-
批准号:7334552
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2007
-
负责人:Steven Upshaw Walkley
-
依托单位:
Substrate Reduction Therapies for Niemann-Pick C Disease
-
批准号:7414358
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2006
-
负责人:Steven Upshaw Walkley
-
依托单位:
Substrate Reduction Therapies for Niemann-Pick C Disease
-
批准号:7252433
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2006
-
负责人:Steven Upshaw Walkley
-
依托单位:
Substrate Reduction Therapies for Niemann-Pick C Disease
-
批准号:7595824
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2006
-
负责人:Steven Upshaw Walkley
-
依托单位:
Substrate Reduction Therapies for Niemann-Pick C Disease
-
批准号:7150511
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2006
-
负责人:Steven Upshaw Walkley
-
依托单位:
Substrate Reduction Therapies for Niemann-Pick C Disease
-
批准号:7803554
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2006
-
负责人:Steven Upshaw Walkley
-
依托单位:
Endosomal-Lysosomal Function in Neuronal Storage Disease
-
批准号:6942308
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2004
-
负责人:Steven Upshaw Walkley
-
依托单位:
Endosomal-Lysosomal Function in Neuronal Storage Disease
-
批准号:7894976
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2004
-
负责人:Steven Upshaw Walkley
-
依托单位:
Endosomal-Lysosomal Function in Neuronal Storage Disease
-
批准号:7069678
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2004
-
负责人:Steven Upshaw Walkley
-
依托单位:
Endosomal-Lysosomal Function in Neuronal Storage Disease
-
批准号:8335479
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2004
-
负责人:Steven Upshaw Walkley
-
依托单位:
国内基金
海外基金
基于深度学习的支气管肺泡灌洗液ROSE自动分析系统的构建和研究
-
批准号:2023JJ50509
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:彭红兵
-
依托单位:
一类离散Hindmarsh-Rose模型的分支延拓
-
批准号:11626029
-
项目类别:数学天元基金项目
-
资助金额:3.0万元
-
批准年份:2016
-
负责人:李波
-
依托单位:
新型ROSE药物输送体系介导的靶向miR-34抗肝癌治疗研究
-
批准号:81502026
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2015
-
负责人:胡奇达
-
依托单位: